Author: Nicole Jupe
Evaluating lab-based and instant drug testing
We presented a webinar with Bill Current about instant vs. lab-based drug testing. Here are some of the most commonly asked questions.
Upcoming wellness webinar
Quest Diagnostics will present a webinar on June 12th entitled, "New Insights into the Value of Biometric Screenings and Outcomes-Based Incentives."
Webinar: Worth the wait? Instant vs. lab-based drug testing
Instant drug testing is one of several terms used to describe a testing method that yields an immediate result where the drug test is administered.
Prescription drug abuse webinar
ExamOne, a Quest Diagnostics company, will present a webcast called "Is Prescription Drug Abuse Affecting Your Mortality?"
Synthetic cannabinoid user profile
The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of the CESAR report.
Follow us on LinkedIn
Quest Diagnostics Employer Solutions has launched a LinkedIn page to post insights and resources on workplace drug screening.
We’re There When You Need Us™ May champion
Nadine Larson, Certifying Scientist, discusses how Quest recognizes the importance of drug testing and that our test results impact people’s lives.
Name that drug: Methadone
The Name that Drug column in DATIA Focus magazine asks readers to guess the mystery substance. Did you know it was methadone?
Oral fluid insights from DATIA
Oral fluid testing was a hot topic at the Drug and Alcohol Testing Industry Association (DATIA) conference this week.
New oral fluid technology identifies marijuana users
The latest Quest Diagnostics Drug Testing Index™ revealed that oral fluid testing is detecting more marijuana positives than other specimen.
